Summary:
- The article discusses a new study that suggests a two-dose vaccine schedule could make HIV vaccines more effective than a single-dose approach.
- Researchers found that a two-dose regimen of an experimental HIV vaccine candidate induced a stronger and more durable immune response in non-human primates compared to a single-dose.
- The findings suggest that a two-dose schedule could be a more effective strategy for developing an HIV vaccine, as it may help the immune system generate a more robust and long-lasting response against the virus.